Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#3777
Protagonist Therapeutics, Inc. - Common Stock
1.0
0
USD
-99.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.01%
Monthly Change
-98.99%
6 month change
-98.89%
Year Change
-98.67%
Previous Close
100.4
1
Open
1.0
0
Low
1.0
0
High
1.0
0
Volume
116
Markets
US Stock Market
Healthcare
PTGX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
43.81 M
48.41 M
51.28 M
58.27 M
61.38 M
63.81 M
64.31 M
Valuation ratios
Enterprise value
765.82 M
1.53 B
427 M
1.18 B
2.27 B
5.44 B
6.2 B
Price to earnings ratio
—
—
-4.15
-16.85
9.13
-42.6
-54.95
Price to sales ratio
—
—
19.89
22.16
5.78
120.66
92.28
Price to cash flow ratio
—
—
-4.89
-18.93
13.64
96.28
-56.53
Price to book ratio
—
—
2.45
3.95
3.72
9.03
2.51
Enterprise value to EBITDA ratio
-8.3
-12.25
-3.28
-12.71
8.96
-34.71
-43.99
Profitability ratios
Return on assets %
-0.2
-0.36
-0.51
-0.22
0.37
-0.19
0.01
Return on equity %
-0.24
-0.42
-0.59
-0.23
0.41
-0.21
0.01
Return on invested capital %
-881.2
-2 568.99
-5 504.26
-6 840.28
655.28
-621.4
-21.4
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-72.17 K
-460.01
-494.24
-156.09
58.2
-343.63
-6.47
EBITDA margin %
-103.21 K
-457.04
-490.35
-154.46
58.39
-340.85
-5.75
Net margin %
-73.99 K
-458.94
-479.26
-131.59
63.34
-282.83
6.71
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.84
7.74
7.8
16.71
12.48
12.71
17.76
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.08
0.09
0.2
0.79
0.07
0.08
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.03
—
—
—
—
—
—
Long term debt to total equity ratio
0.04
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.2
-1.24
2.83
0.91
-1.76
EBIT per share
—
—
-2.68
-1.65
3.89
-2.49
-2.23
EBITDA per share
—
—
-2.66
-1.63
3.9
-2.47
-2.21
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.84
6.02
6.44
8.92
7.77
Net current asset value per share
—
—
4.96
6.26
9.09
9.09
8.7
Tangible book value per share
—
—
4.4
5.93
10.38
9.67
9.3
Working capital per share
—
—
4.32
5.89
8.36
8.37
8.21
Book value per share
—
—
4.4
5.93
10.38
9.67
9.3
News
J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?
J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?
J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?
J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth
Tremfya, Icotyde Lead J&J's Post-Stelara Immunology Strategy
How to Play J&J Stock Post a Beat-and-Raise Performance in Q1
Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)
J&J raises guidance for 2026 on strong start to the year
Growth vs. Stability: Lilly and J&J's 2026 Investment Face-Off
Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?
J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?